Clin2
NCT07794813Likely a fitRecruiting

Imaging agent for clearer tumor removal in oral cancer surgery

Oral Squamous Cell Carcinoma (OSCC)Diagnosis

Part of Cancer clinical trials.

This study tests a new imaging agent that helps surgeons see oral tumors more clearly during surgery. It aims to improve the accuracy of tumor removal.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
40 people
Ages
18 years to 75 years
Study type
Observational

Who can take part

  • You must be between 18 and 75 years old.
  • You must have oral cancer or a benign tumor in the mouth.
  • You must be scheduled for surgery to remove the tumor.
  • You must not have any other type of cancer.
  • You must not have any serious health conditions that would prevent surgery.
  • You must be able to give informed consent to participate.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07778368Not yet recruiting· Phase 2
Two-drug pre-surgery treatment for locally advanced oral cancer

This study tests whether giving a combination of two medications before surgery can help shrink oral cancer tumors and improve treatment outcomes. The medications are a targeted therapy (called TROP-2 ADC) and an immunotherapy (called toripalimab), and you would receive them before your planned surgery.

Shanghai
NCT06972771Recruiting
Imaging to help find bladder cancer during surgery

This trial tests a special imaging dye that lights up bladder cancer during surgery, helping doctors see and remove it more precisely. It may help ensure all cancer is removed while sparing healthy tissue.

Kunming, Yunnan
NCT07848854Recruiting· Phase 2
New imaging test to spot bladder cancer during surgery

This trial tests a special dye that binds to bladder cancer cells and makes them glow during surgery. It may help doctors find and remove the cancer more completely.

Kunming, Yunnan
NCT07800507Not yet recruiting· Phase 1/Phase 2
Fluorescent dye to guide bladder tumor removal

This trial tests whether a special fluorescent dye (given before surgery) can make bladder tumor removal more precise by helping the surgeon see exactly where the tumor is during the operation. It aims to reduce the chance of leaving cancerous tissue behind.

Kunming, Yunnan
NCT07149207Recruiting· Phase 2
Using a dye during head and neck cancer surgery

This study tests whether a special dye (ICG) injected before surgery can help surgeons see head and neck cancer more clearly during the operation. It is for people with squamous cell carcinoma who are at risk of their cancer returning and are scheduled for surgery.

Charleston, South Carolina
NCT07254845Not yet recruiting· Phase 1
New imaging tool for brain tumor surgery

This trial tests a new imaging tool that helps surgeons look at brain tissue during your operation, so they can make faster and more accurate diagnoses. It may help guide the surgery to remove as much tumor as possible while preserving healthy brain.

Hear when a new Diagnosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.